From Google Scholar+ [to 28 June 2014]

From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary

Journal of AIDS & Clinical Research
2014, 5:5
http://dx.doi.org/10.4172/2155-6113.1000298
Commentary
The Pursuit of a HIV Vaccine–Trials, Challenges and Strategies
Nageswara Rao Alla*
Department of Pulmonary Allergy and Critical Care medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, USA
This is an open-access article.
Abstract
The search for a HIV vaccine that can elicit potent, long lasting and broad immune responses to both prevent acquisition of infection and control viral replication has been going on for over two decades. The modest success of the RV144 vaccine efficacy trial and isolation of broadly neutralizing antibodies capable of neutralizing different HIV strains has reinvigorated research in antibody based vaccine design and development strategies. This review will discuss the efficacy trials conducted to date, lessons learned from the trials, challenges and current strategies being pursued in the HIV vaccine field.

PharmacoEconomics & Outcomes News
June 2014, Volume 705, Issue 1, p 5
Boosting HPV vaccination of pre-teen boys by social marketing
JR Cates – PharmacoEconomics & Outcomes News, 2014
Excerpt
A social marketing campaign may be successfully used to promote human papillomavirus (HPV) vaccination of pre-teen boys, say researchers from the US.
The researchers evaluated a campaign, entitled “Protect Him”, that was conducted to motivate parents of pre-teen boys to initiate HPV vaccination and healthcare providers to start the vaccine series at the recommended ages of 11−12 years. The intervention was conducted in 13 counties in North Carolina over a 3-month period in 2012 and included a set of social marketing strategies, such as public radio announcements, posters, brochures, online medical education for providers and information on a website.
The analysis of data from the North Carolina Immunization Registry showed that the intervention had a modest but significant effect during the intervention period, with a significantly larger increase in vaccination rates in 9−13-year-old boys in the intervention counties, compared with control counties.
Special Focus Newsletters
Rotaflash
PATH – June 24, 2014
Rotavirus vaccines reach Djibouti, Togo, and Uzbekistan
Civil society organizations (CSOs) in Togo mobilize and motivate rural communities to vaccinate their children

DVI Newsletter
Dengue Vaccine Initiative – June 2014
In this issue of the DVI Dengue Champion Spotlight we feature Dr. Arunee Sabchareon for significantly deepening our knowledge of dengue in Asia, dengue infections, and the dengue vaccine.